Andrew F Calman, MD
Ophthalmology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 3
- Since medical school
- 37 years
- University of California, San Francisco School of Medicine, 1989
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Calman’s office at (415) 600-6000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G69615 · Current
Licensed to practise in California · since 1990 · expires 2028-06-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$359,451
Medicare paid this office $359,451 for 624 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 448 | $68,484 | $109 |
| Exam of visual field with extended testing | 381 | $38,939 | $60 |
| Established patient problem focused exam of visual system | 202 | $25,856 | $83 |
| Laser repair to improve eye fluid flow | 55 | $20,431 | $238 |
| Imaging of optic nerve | 358 | $17,014 | $33 |
See all 18 services
| Established patient complete exam of visual system | 448 | $68,484 | $109 |
| Exam of visual field with extended testing | 381 | $38,939 | $60 |
| Established patient problem focused exam of visual system | 202 | $25,856 | $83 |
| Laser repair to improve eye fluid flow | 55 | $20,431 | $238 |
| Imaging of optic nerve | 358 | $17,014 | $33 |
| Removal of cataract with insertion of prosthetic lens | 25 | $16,492 | $515 |
| Return visit (30+ min) | 114 | $14,050 | $100 |
| Injection of drug into eye | 21 | $13,506 | $111 |
| Imaging of retina | 161 | $11,565 | $37 |
| Photography of the retina | 187 | $6,682 | $33 |
| Long return visit (40+ min) | 33 | $6,134 | $150 |
| Short return visit (20+ min) | 60 | $5,700 | $79 |
| New patient visit (60+ min) | 32 | $5,096 | $159 |
| New patient visit (45+ min) | 24 | $3,390 | $141 |
| Short return visit | 49 | $2,899 | $53 |
| Exam of the internal drainage system of eye | 83 | $2,465 | $27 |
| Measurement of corneal curvature and depth of eye | 33 | $2,460 | $46 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $519 | $24 |
Procedures Medicare counted
| Cataract surgery | 24 | More than 48% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of drug into eye | 348 | 217 | 272 | 212 | 222 | 122 |
| Laser repair to improve eye fluid flow | 66 | 69 | 67 | 56 | 77 | 86 |
| Removal of cataract with insertion of prosthetic lens | 90 | 20 | 27 | 30 | 24 | 32 |
| Destruction of growth of retina using a laser | 31 | 28 | 28 | 19 | – | – |
| Closure of tear duct opening using plug | 20 | – | 43 | 33 | – | – |
| Removal of recurring cataract in lens capsule using a laser | 15 | – | 17 | 12 | 12 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
624 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 21% · Women 57% · Also on Medicaid 49% · Health risk score 1.22. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 41% · Chronic kidney disease 23% · Coronary heart disease 17% · Depression 17% · Heart failure 13% · Atrial fibrillation 13% · Cancer 11% · COPD 9% · Dementia 8% · Stroke 5%.
The office billed $1,151,817, Medicare allowed $490,814 and paid $359,451; for 4,717 services of 50 kinds; $68,657 of it was for drugs given in the office and $290,794 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 624 | 4,717 | 77 | 1.22 | $1,151,817 | $359,451 |
| 2023 | 693 | 6,997 | 77 | 1.21 | $1,599,913 | $507,390 |
| 2022 | 731 | 5,385 | 77 | 1.14 | $1,514,864 | $599,699 |
| 2021 | 820 | 5,251 | 76 | 1.22 | $1,778,034 | $735,253 |
| 2020 | 808 | 4,826 | 76 | 1.31 | $1,460,963 | $595,962 |
| 2019 | 958 | 6,684 | 76 | 1.30 | $2,139,826 | $749,947 |
| 2018 | 969 | 6,596 | 76 | 1.29 | $2,195,459 | $830,654 |
| 2017 | 657 | 3,462 | 76 | 1.34 | $1,490,755 | $718,036 |
| 2016 | 264 | 2,498 | 77 | 1.41 | $1,633,830 | $767,973 |
| 2015 | 312 | 3,289 | 76 | 1.44 | $1,523,398 | $728,819 |
| 2014 | 496 | 3,606 | 76 | 1.46 | $1,408,738 | $642,462 |
| 2013 | 456 | 2,854 | 77 | 1.50 | $1,198,546 | $496,431 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Injection, aflibercept, 1 mg | 13 | $90,961 | None |
| Established patient complete exam of visual system | 466 | $61,002 | $103 |
| Exam of visual field with extended testing | 417 | $42,804 | $58 |
| Return visit (30+ min) | 237 | $37,218 | $110 |
| Injection of drug into eye | 26 | $24,068 | $108 |
| Established patient problem focused exam of visual system | 201 | $23,101 | $76 |
| Laser repair to improve eye fluid flow | 48 | $17,846 | $232 |
| Imaging of optic nerve | 380 | $17,052 | $33 |
| Imaging of retina | 158 | $13,881 | $37 |
| Removal of cataract with insertion of prosthetic lens | 22 | $11,980 | $499 |
| Photography of the retina | 317 | $11,441 | $34 |
| Short return visit (20+ min) | 86 | $9,824 | $81 |
| New patient visit (45+ min) | 61 | $6,982 | $114 |
| Injection, bevacizumab, 10 mg | 17 | $6,182 | None |
| New patient visit (60+ min) | 30 | $5,558 | $185 |
| Long return visit (40+ min) | 29 | $4,666 | $146 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $4,033 | $336 |
| Short return visit | 57 | $3,232 | $51 |
| Exam of the internal drainage system of eye | 92 | $2,682 | $27 |
| New patient complete exam of visual system | 11 | $1,433 | $130 |
| Measurement of corneal curvature and depth of eye | 26 | $1,325 | $46 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $640 | $23 |
2022: 26 services
| Injection, aflibercept, 1 mg | 24 | $222,150 | None |
| Established patient complete exam of visual system | 537 | $71,651 | $99 |
| Exam of visual field with extended testing | 451 | $48,329 | $57 |
| Established patient problem focused exam of visual system | 349 | $44,769 | $80 |
| Injection of drug into eye | 34 | $23,035 | $109 |
| Return visit (30+ min) | 156 | $22,354 | $114 |
| Imaging of optic nerve | 436 | $17,310 | $32 |
| Imaging of retina | 171 | $14,344 | $37 |
| Removal of cataract with insertion of prosthetic lens | 27 | $13,869 | $462 |
| Laser repair to improve eye fluid flow | 34 | $13,040 | $233 |
| Photography of the retina | 355 | $11,995 | $32 |
| Destruction of growth of retina using a laser | 14 | $9,413 | $495 |
| New patient visit (45+ min) | 47 | $5,917 | $126 |
| Short return visit (20+ min) | 70 | $5,589 | $76 |
| New patient visit (60+ min) | 21 | $3,651 | $174 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,642 | $304 |
| Closure of tear duct opening using plug | 13 | $3,366 | $102 |
| Injection, bevacizumab, 10 mg | 14 | $3,167 | None |
| Long return visit (40+ min) | 15 | $2,697 | $135 |
| Short return visit | 52 | $2,664 | $48 |
| Exam of the internal drainage system of eye | 91 | $2,539 | $25 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 19 | $2,149 | $113 |
| Measurement of corneal curvature and depth of eye | 36 | $1,947 | $46 |
| New patient complete exam of visual system | 15 | $1,690 | $113 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $565 | $24 |
| Ultrasound scan of cornea to determine thickness | 11 | $103 | $9 |
2021: 28 services
| Injection, aflibercept, 1 mg | 29 | $340,791 | None |
| Established patient complete exam of visual system | 588 | $90,783 | $105 |
| Established patient problem focused exam of visual system | 331 | $42,258 | $76 |
| Exam of visual field with extended testing | 443 | $39,853 | $59 |
| Injection of drug into eye | 38 | $30,112 | $111 |
| Imaging of retina | 261 | $21,675 | $38 |
| Imaging of optic nerve | 431 | $17,670 | $32 |
| Laser repair to improve eye fluid flow | 41 | $16,017 | $239 |
| Destruction of growth of retina using a laser | 17 | $13,893 | $496 |
| Removal of cataract with insertion of prosthetic lens | 24 | $12,396 | $459 |
| Return visit (30+ min) | 70 | $10,605 | $125 |
| Photography of the retina | 255 | $10,013 | $36 |
| Short return visit (20+ min) | 88 | $8,581 | $88 |
| New patient visit (45+ min) | 63 | $8,129 | $129 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $5,687 | $335 |
| Closure of tear duct opening using plug | 18 | $5,421 | $126 |
| Long return visit (40+ min) | 26 | $4,605 | $171 |
| New patient visit (60+ min) | 24 | $4,344 | $181 |
| New patient complete exam of visual system | 36 | $4,309 | $120 |
| Exam of the internal drainage system of eye | 129 | $4,166 | $26 |
| Short return visit | 36 | $2,101 | $51 |
| Injection, bevacizumab, 10 mg | 13 | $2,031 | None |
| Exam of retinal blood vessels using a special camera after injection of a dye | 14 | $1,972 | $123 |
| Measurement of corneal curvature and depth of eye | 28 | $1,893 | $56 |
| Telephone medical discussion with physician, 5-10 minutes | 19 | $496 | $24 |
| Photography of content of eyes | 14 | $338 | $24 |
| Ultrasound scan of cornea to determine thickness | 27 | $300 | $10 |
| Removal of eyelashes using forceps | 11 | $214 | $18 |
2020: 23 services
| Injection, aflibercept, 1 mg | 28 | $239,240 | None |
| Established patient complete exam of visual system | 587 | $91,421 | $103 |
| Established patient problem focused exam of visual system | 372 | $48,872 | $79 |
| Exam of visual field with extended testing | 426 | $36,336 | $60 |
| Imaging of retina | 277 | $20,888 | $37 |
| Injection of drug into eye | 37 | $20,542 | $95 |
| Imaging of optic nerve | 427 | $17,689 | $33 |
| Laser repair to improve eye fluid flow | 44 | $16,472 | $239 |
| Destruction of growth of retina using a laser | 18 | $14,113 | $504 |
| New patient visit (45+ min) | 89 | $11,218 | $126 |
| Removal of cataract with insertion of prosthetic lens | 17 | $9,525 | $476 |
| Photography of the retina | 184 | $7,679 | $40 |
| Exam of the internal drainage system of eye | 126 | $3,724 | $26 |
| Injection, bevacizumab, 10 mg | 26 | $3,182 | None |
| Short return visit | 51 | $2,421 | $41 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 19 | $2,039 | $107 |
| Measurement of corneal curvature and depth of eye | 20 | $1,659 | $61 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $1,643 | $40 |
| Short return visit (20+ min) | 18 | $1,394 | $70 |
| New patient visit (30+ min) | 13 | $1,129 | $87 |
| Telephone medical discussion with physician, 5-10 minutes | 32 | $754 | $22 |
| Ultrasound scan of cornea to determine thickness | 42 | $489 | $11 |
| Photography of content of eyes | 24 | $462 | $18 |
2019: 25 services
| Injection, aflibercept, 1 mg | 23 | $221,034 | None |
| Established patient complete exam of visual system | 778 | $138,687 | $104 |
| Established patient problem focused exam of visual system | 435 | $57,770 | $78 |
| Removal of cataract with insertion of prosthetic lens | 67 | $53,172 | $591 |
| Exam of visual field with extended testing | 521 | $48,846 | $60 |
| Injection of drug into eye | 50 | $32,801 | $94 |
| Imaging of retina | 348 | $32,128 | $38 |
| Imaging of optic nerve | 522 | $21,514 | $33 |
| New patient visit (45+ min) | 135 | $16,856 | $125 |
| Laser repair to improve eye fluid flow | 37 | $15,556 | $236 |
| Destruction of growth of retina using a laser | 16 | $15,423 | $498 |
| Photography of the retina | 317 | $15,411 | $46 |
| Injection, bevacizumab, 10 mg | 41 | $13,185 | None |
| Measurement of corneal curvature and depth of eye | 70 | $6,182 | $69 |
| Exam of the internal drainage system of eye | 184 | $5,939 | $25 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $4,898 | $327 |
| Closure of tear duct opening using plug | 11 | $2,370 | $119 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 23 | $2,218 | $92 |
| Short return visit | 39 | $1,705 | $42 |
| New patient visit (30+ min) | 20 | $1,529 | $76 |
| Photography of content of eyes | 69 | $1,525 | $21 |
| 2d ultrasound scan of eye tissue and structures | 14 | $956 | $56 |
| Ultrasound scan of cornea to determine thickness | 63 | $733 | $11 |
| Removal of eyelashes using forceps | 17 | $650 | $30 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $227 | $19 |
2018: 21 services
| Injection, aflibercept, 1 mg | 35 | $315,460 | None |
| Established patient complete exam of visual system | 794 | $147,013 | $105 |
| Injection of drug into eye | 69 | $46,386 | $92 |
| Established patient problem focused exam of visual system | 326 | $41,486 | $78 |
| Exam of visual field with extended testing | 475 | $40,234 | $62 |
| Imaging of retina | 346 | $35,008 | $39 |
| Destruction of growth of retina using a laser | 35 | $27,603 | $493 |
| Removal of cataract with insertion of prosthetic lens | 42 | $27,094 | $602 |
| Imaging of optic nerve | 516 | $20,252 | $33 |
| Injection, bevacizumab, 10 mg | 51 | $17,661 | None |
| Photography of the retina | 302 | $16,451 | $52 |
| New patient visit (45+ min) | 118 | $15,661 | $133 |
| Laser repair to improve eye fluid flow | 32 | $10,489 | $233 |
| Exam of the internal drainage system of eye | 199 | $5,724 | $24 |
| Measurement of corneal curvature and depth of eye | 43 | $4,132 | $75 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 40 | $3,503 | $80 |
| New patient complete exam of visual system | 20 | $2,428 | $121 |
| Short return visit | 53 | $2,266 | $39 |
| Removal of eyelashes using forceps | 17 | $765 | $35 |
| Ultrasound scan of cornea to determine thickness | 43 | $586 | $14 |
| Photography of content of eyes | 20 | $430 | $20 |
2017: 21 services
| Injection, aflibercept, 1 mg | 41 | $463,230 | None |
| Established patient complete exam of visual system | 452 | $62,007 | $119 |
| Injection of drug into eye | 55 | $41,300 | $96 |
| Removal of cataract with insertion of prosthetic lens | 37 | $27,108 | $602 |
| Imaging of retina | 225 | $14,797 | $40 |
| Established patient problem focused exam of visual system | 125 | $14,242 | $83 |
| Exam of visual field with extended testing | 161 | $10,951 | $63 |
| Destruction of growth of retina using a laser | 16 | $10,140 | $483 |
| Photography of the retina | 140 | $10,037 | $67 |
| New patient visit (45+ min) | 61 | $8,839 | $145 |
| Injection, bevacizumab, 10 mg | 33 | $7,640 | None |
| Laser repair to improve eye fluid flow | 20 | $7,019 | $226 |
| Imaging of optic nerve | 157 | $5,581 | $35 |
| Short return visit (20+ min) | 27 | $2,342 | $69 |
| Exam of the internal drainage system of eye | 85 | $2,223 | $26 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 27 | $2,190 | $76 |
| New patient complete exam of visual system | 14 | $2,019 | $144 |
| Measurement of corneal curvature and depth of eye | 14 | $1,476 | $92 |
| Short return visit | 27 | $1,138 | $41 |
| Microfluid analysis of tears | 16 | $689 | $22 |
| Ultrasound scan of cornea to determine thickness | 32 | $431 | $13 |
2016: 13 services
| Injection, aflibercept, 1 mg | 47 | $565,814 | None |
| Removal of cataract with insertion of prosthetic lens | 68 | $48,802 | $610 |
| Injection of drug into eye | 61 | $43,051 | $96 |
| Destruction of growth of retina using a laser | 24 | $19,302 | $495 |
| Laser repair to improve eye fluid flow | 42 | $17,351 | $271 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 71 | $14,044 | $103 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $7,193 | $327 |
| Photography of the retina | 80 | $6,118 | $71 |
| Short return visit | 76 | $3,217 | $40 |
| Injection, bevacizumab, 10 mg | 20 | $2,342 | None |
| Established patient complete exam of visual system | 21 | $2,090 | $95 |
| Imaging of retina | 21 | $975 | $44 |
| Established patient problem focused exam of visual system | 11 | $845 | $77 |
2015: 18 services
| Injection, aflibercept, 1 mg | 52 | $452,604 | None |
| Removal of cataract with insertion of prosthetic lens | 64 | $45,039 | $609 |
| Injection of drug into eye | 69 | $41,697 | $97 |
| Laser repair to improve eye fluid flow | 65 | $30,517 | $311 |
| Destruction of growth of retina using a laser | 28 | $19,093 | $490 |
| Destruction of leaking blood vessels of retina using laser | 11 | $17,891 | $942 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 61 | $12,346 | $105 |
| Complex removal of cataract with insertion of prosthetic lens | 16 | $12,122 | $758 |
| Photography of the retina | 80 | $6,393 | $73 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 11 | $6,247 | $284 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $4,468 | $319 |
| Unclassified biologics | 26 | $3,649 | None |
| Established patient complete exam of visual system | 40 | $3,180 | $79 |
| Short return visit | 73 | $2,978 | $39 |
| Established patient problem focused exam of visual system | 18 | $1,651 | $69 |
| Imaging of retina | 27 | $1,280 | $43 |
| Exam of visual field with extended testing | 18 | $1,084 | $60 |
| Injection, bevacizumab, 10 mg | 12 | $864 | None |
2014: 22 services
| Injection, aflibercept, 1 mg | 31 | $213,095 | None |
| Injection, ranibizumab, 0.1 mg | 14 | $67,698 | None |
| Removal of cataract with insertion of prosthetic lens | 72 | $51,180 | $609 |
| Destruction of leaking blood vessels of retina using laser | 40 | $51,128 | $965 |
| Laser repair to improve eye fluid flow | 88 | $46,557 | $326 |
| Injection of drug into eye | 58 | $31,371 | $96 |
| Destruction of growth of retina using a laser | 41 | $28,045 | $492 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 103 | $22,807 | $102 |
| Established patient complete exam of visual system | 162 | $20,604 | $113 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 28 | $14,629 | $293 |
| Photography of the retina | 159 | $13,923 | $73 |
| Established patient problem focused exam of visual system | 99 | $12,649 | $82 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $11,424 | $762 |
| Imaging of retina | 91 | $8,264 | $44 |
| Short return visit | 130 | $5,930 | $41 |
| Exam of visual field with extended testing | 73 | $4,931 | $64 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $4,782 | $319 |
| Unclassified biologics | 26 | $4,049 | None |
| New patient visit (45+ min) | 21 | $2,973 | $142 |
| Imaging of optic nerve | 62 | $2,512 | $41 |
| Exam of the internal drainage system of eye | 40 | $1,102 | $26 |
| Injection, bevacizumab, 10 mg | 17 | $864 | None |
2013: 21 services
| Injection, aflibercept, 1 mg | 18 | $118,894 | None |
| Injection, ranibizumab, 0.1 mg | 12 | $58,593 | None |
| Removal of cataract with insertion of prosthetic lens | 78 | $55,052 | $612 |
| Laser repair to improve eye fluid flow | 93 | $50,985 | $321 |
| Destruction of growth of retina using a laser | 43 | $37,193 | $496 |
| Injection of drug into eye | 59 | $24,650 | $92 |
| Established patient complete exam of visual system | 158 | $18,489 | $108 |
| Established patient problem focused exam of visual system | 102 | $14,590 | $78 |
| Destruction of leaking blood vessels of retina using laser | 12 | $14,417 | $961 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 74 | $13,977 | $101 |
| Imaging of retina | 103 | $9,991 | $44 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 18 | $9,251 | $289 |
| Photography of the retina | 95 | $7,294 | $71 |
| Injection, bevacizumab, 10 mg | 41 | $5,932 | None |
| Removal of recurring cataract in lens capsule using a laser | 17 | $5,351 | $297 |
| Exam of visual field with extended testing | 73 | $4,707 | $63 |
| Imaging of optic nerve | 58 | $2,407 | $41 |
| New patient visit (45+ min) | 13 | $1,892 | $146 |
| Short return visit | 30 | $1,318 | $41 |
| Exam of the internal drainage system of eye | 40 | $1,043 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $203 | $18 |
Medicaid work
$24,813 in 2024
Medicaid paid $24,813 for 139 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 71 | $16,722 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 54 | $6,462 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 14 | $1,629 |
| 2024 | 139 | 3 | 22 | $24,813 |
| 2023 | 355 | 5 | 30 | $43,726 |
| 2020 | 13 | 1 | 12 | $293 |
| 2019 | 226 | 3 | 23 | $1,227 |
| 2018 | 253 | 5 | 27 | $0 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 108 | $18,302 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 131 | $12,682 |
| Return visit (30+ min) | 29 | $5,341 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 26 | $3,812 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 61 | $3,589 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $293 |
2019
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 159 | $1,227 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 42 | $0 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 25 | $0 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 30 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 172 | $0 |
| GONIOSCOPY | 12 | $0 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 12 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 27 | $0 |
Drugs they prescribed that Part D paid
$202,965
Pharmacies billed $202,965 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,551) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
810 generic and 741 brand-name prescriptions · $202,965 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 121 | $67,740 | $560 |
| Restasis | 19 | $21,685 | $1,141 |
| Xiidra | 16 | $17,108 | $1,069 |
| Cyclosporine | 25 | $13,779 | $551 |
| Rocklatan | 15 | $9,123 | $608 |
See all 25 drugs
| Lumigan | 121 | $67,740 | $560 |
| Restasis | 19 | $21,685 | $1,141 |
| Xiidra | 16 | $17,108 | $1,069 |
| Cyclosporine | 25 | $13,779 | $551 |
| Rocklatan | 15 | $9,123 | $608 |
| Combigan | 15 | $8,599 | $573 |
| Simbrinza | 26 | $6,465 | $249 |
| Travoprost | 33 | $6,376 | $193 |
| Rhopressa | 14 | $4,402 | $314 |
| Brimonidine | 64 | $3,895 | $61 |
| Brimonidine Tartrate-Timolol | 15 | $3,593 | $240 |
| Prednisolone Acetate | 117 | $3,562 | $30 |
| Gatifloxacin | 74 | $3,381 | $46 |
| Latanoprost | 345 | $3,179 | $9 |
| Bimatoprost | 23 | $2,691 | $117 |
| Fluorometholone | 24 | $1,834 | $76 |
| Brinzolamide | 13 | $1,822 | $140 |
| Dorzolamide | 131 | $1,749 | $13 |
| Ketorolac Tromethamine | 94 | $1,736 | $18 |
| Travatan Z | 11 | $1,439 | $131 |
| Diclofenac | 141 | $1,309 | $9 |
| Timolol Maleate | 81 | $549 | $7 |
| Dorzolamide-Timolol | 36 | $535 | $15 |
| Tobramycin-Dexamethasone | 16 | $407 | $25 |
| Polymyxin B Sul-Trimethoprim | 29 | $197 | $7 |
Year by year
| 2024 | 1,551 | 320 | 0% (0) | 48% | $202,965 |
| 2023 | 1,117 | 264 | 0% (0) | 54% | $222,080 |
| 2022 | 667 | 192 | 0% (0) | 62% | $145,488 |
| 2021 | 397 | 155 | 0% (0) | 51% | $160,727 |
| 2020 | 169 | 70 | 0% (0) | 60% | $133,274 |
| 2019 | 229 | 78 | 0% (0) | 70% | $50,242 |
| 2018 | 287 | 76 | 0% (0) | 70% | $56,300 |
| 2017 | 349 | 74 | 0% (0) | 67% | $56,471 |
| 2016 | 692 | 151 | 0% (0) | 72% | $103,259 |
| 2015 | 1,050 | 222 | 0% (0) | 70% | $135,676 |
| 2014 | 1,168 | 243 | None | 76% | $149,341 |
| 2013 | 1,344 | 259 | None | 78% | $147,815 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Lumigan | 132 | $78,703 | $596 |
| Restasis | 16 | $32,326 | $2,020 |
| Simbrinza | 34 | $8,822 | $259 |
| Travoprost | 24 | $6,829 | $285 |
| Rhopressa | 16 | $5,395 | $337 |
| Prednisolone Acetate | 105 | $4,675 | $45 |
| Latanoprost | 216 | $4,474 | $21 |
| Brimonidine | 39 | $3,347 | $86 |
| Alphagan P | 11 | $3,262 | $297 |
| Brimonidine Tartrate-Timolol | 11 | $3,114 | $283 |
| Bimatoprost | 16 | $3,016 | $188 |
| Dorzolamide | 99 | $2,757 | $28 |
| Gatifloxacin | 33 | $1,641 | $50 |
| Ketorolac Tromethamine | 64 | $1,284 | $20 |
| Diclofenac | 79 | $952 | $12 |
| Tobramycin-Dexamethasone | 12 | $656 | $55 |
| Timolol Maleate | 62 | $638 | $10 |
| Polymyxin B Sul-Trimethoprim | 40 | $413 | $10 |
| Dorzolamide-Timolol | 13 | $363 | $28 |
2022: 16 drugs
| Lumigan | 72 | $37,075 | $515 |
| Restasis | 27 | $33,976 | $1,258 |
| Simbrinza | 50 | $12,636 | $253 |
| Rhopressa | 31 | $9,913 | $320 |
| Travoprost | 22 | $5,896 | $268 |
| Alphagan P | 12 | $3,691 | $308 |
| Prednisolone Acetate | 61 | $2,617 | $43 |
| Latanoprost | 95 | $2,050 | $22 |
| Bimatoprost | 11 | $1,966 | $179 |
| Brimonidine | 24 | $1,260 | $53 |
| Dorzolamide | 39 | $885 | $23 |
| Dorzolamide-Timolol | 20 | $700 | $35 |
| Ketorolac Tromethamine | 39 | $677 | $17 |
| Polymyxin B Sul-Trimethoprim | 34 | $320 | $9 |
| Timolol Maleate | 26 | $290 | $11 |
| Diclofenac | 18 | $185 | $10 |
2021: 8 drugs
| Lumigan | 48 | $24,076 | $502 |
| Simbrinza | 16 | $3,831 | $239 |
| Prednisolone Acetate | 32 | $1,387 | $43 |
| Diclofenac | 72 | $1,340 | $19 |
| Latanoprost | 38 | $963 | $25 |
| Tobramycin-Dexamethasone | 11 | $881 | $80 |
| Ketorolac Tromethamine | 23 | $810 | $35 |
| Polymyxin B Sul-Trimethoprim | 27 | $229 | $8 |
2020: 6 drugs
| Lumigan | 42 | $19,846 | $473 |
| Prednisolone Acetate | 16 | $827 | $52 |
| Ketorolac Tromethamine | 18 | $487 | $27 |
| Latanoprost | 15 | $433 | $29 |
| Diclofenac | 27 | $365 | $14 |
| Timolol Maleate | 12 | $131 | $11 |
2019: 7 drugs
| Lumigan | 59 | $24,015 | $407 |
| Travatan Z | 46 | $15,108 | $328 |
| Azopt | 14 | $4,374 | $312 |
| Prednisolone Acetate | 17 | $1,041 | $61 |
| Latanoprost | 15 | $354 | $24 |
| Diclofenac | 18 | $285 | $16 |
| Timolol Maleate | 16 | $199 | $12 |
2018: 7 drugs
| Lumigan | 58 | $22,369 | $386 |
| Travatan Z | 68 | $18,314 | $269 |
| Azopt | 28 | $8,594 | $307 |
| Prednisolone Acetate | 12 | $1,053 | $88 |
| Latanoprost | 29 | $618 | $21 |
| Dorzolamide-Timolol | 13 | $461 | $35 |
| Timolol Maleate | 23 | $286 | $12 |
2017: 8 drugs
| Lumigan | 78 | $24,074 | $309 |
| Travatan Z | 55 | $13,939 | $253 |
| Azopt | 27 | $7,604 | $282 |
| Prednisolone Acetate | 20 | $1,530 | $76 |
| Dorzolamide-Timolol | 33 | $1,063 | $32 |
| Latanoprost | 47 | $974 | $21 |
| Diclofenac | 13 | $296 | $23 |
| Timolol Maleate | 24 | $157 | $7 |
2016: 14 drugs
| Lumigan | 120 | $35,468 | $296 |
| Travatan Z | 92 | $22,899 | $249 |
| Azopt | 38 | $10,503 | $276 |
| Ilevro | 34 | $8,687 | $255 |
| Durezol | 26 | $4,001 | $154 |
| Prednisolone Acetate | 55 | $3,227 | $59 |
| Nevanac | 13 | $2,978 | $229 |
| Gatifloxacin | 28 | $2,369 | $85 |
| Simbrinza | 14 | $1,852 | $132 |
| Latanoprost | 95 | $1,393 | $15 |
| Dorzolamide-Timolol | 33 | $797 | $24 |
| Diclofenac | 44 | $641 | $15 |
| Polymyxin B Sul-Trimethoprim | 28 | $259 | $9 |
| Timolol Maleate | 19 | $130 | $7 |
2015: 19 drugs
| Lumigan | 167 | $43,930 | $263 |
| Travatan Z | 129 | $26,188 | $203 |
| Ilevro | 51 | $13,098 | $257 |
| Azopt | 46 | $11,437 | $249 |
| Prednisolone Acetate | 100 | $4,871 | $49 |
| Combigan | 28 | $4,524 | $162 |
| Alphagan P | 15 | $4,273 | $285 |
| Gatifloxacin | 30 | $3,233 | $108 |
| Latanoprost | 149 | $2,249 | $15 |
| Simbrinza | 12 | $2,058 | $172 |
| Pataday | 12 | $1,880 | $157 |
| Durezol | 11 | $1,602 | $146 |
| Tobramycin-Dexamethasone | 12 | $1,077 | $90 |
| Dorzolamide-Timolol | 45 | $1,076 | $24 |
| Diclofenac | 64 | $981 | $15 |
| Brimonidine | 24 | $632 | $26 |
| Timolol Maleate | 37 | $511 | $14 |
| Polymyxin B Sul-Trimethoprim | 28 | $290 | $10 |
| Dorzolamide | 13 | $285 | $22 |
2014: 18 drugs
| Lumigan | 236 | $51,552 | $218 |
| Travatan Z | 127 | $24,280 | $191 |
| Azopt | 94 | $16,480 | $175 |
| Combigan | 51 | $7,458 | $146 |
| Alphagan P | 33 | $6,837 | $207 |
| Ilevro | 24 | $4,778 | $199 |
| Latanoprost | 175 | $3,577 | $20 |
| Prednisolone Acetate | 66 | $3,279 | $50 |
| Nevanac | 18 | $2,982 | $166 |
| Durezol | 19 | $2,524 | $133 |
| Gatifloxacin | 22 | $2,015 | $92 |
| Dorzolamide-Timolol | 54 | $1,874 | $35 |
| Brimonidine | 19 | $1,804 | $95 |
| Pataday | 11 | $1,593 | $145 |
| Diclofenac | 43 | $961 | $22 |
| Timolol Maleate | 55 | $904 | $16 |
| Dorzolamide | 23 | $754 | $33 |
| Polymyxin B Sul-Trimethoprim | 11 | $119 | $11 |
2013: 19 drugs
| Lumigan | 266 | $46,588 | $175 |
| Travatan Z | 190 | $31,377 | $165 |
| Azopt | 99 | $15,501 | $157 |
| Alphagan P | 57 | $10,004 | $176 |
| Nevanac | 51 | $7,561 | $148 |
| Restasis | 17 | $5,520 | $325 |
| Latanoprost | 205 | $4,044 | $20 |
| Brimonidine | 37 | $3,440 | $93 |
| Istalol | 16 | $3,245 | $203 |
| Combigan | 27 | $2,905 | $108 |
| Patanol | 16 | $2,192 | $137 |
| Dorzolamide-Timolol | 53 | $2,109 | $40 |
| Betoptic S | 11 | $2,067 | $188 |
| Durezol | 11 | $1,356 | $123 |
| Timolol Maleate | 82 | $1,030 | $13 |
| Prednisolone Acetate | 59 | $883 | $15 |
| Diclofenac | 42 | $692 | $16 |
| Pilocarpine | 12 | $677 | $56 |
| Dorzolamide | 15 | $529 | $35 |
Money from drug and device companies
$75 in 2025
| 2025 | 2 | 3 | None | $75 |
| 2024 | 9 | 12 | None | $465 |
| 2023 | 6 | 13 | None | $367 |
| 2022 | 6 | 10 | None | $258 |
| 2021 | 7 | 9 | None | $285 |
| 2020 | 3 | 8 | $10,637 | $10,742 |
| 2019 | 4 | 12 | None | $1,256 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Xiidra | $40 | 2 payments
|
| Abbvie | Lumigan | $34 | 1 payment
|
See all 3 published payments
| Abbvie | Meals · 2025-04-04 | Lumigan | $34 |
| Bausch & Lomb Americas | Meals · 2025-03-31 | Xiidra | $21 |
| Bausch & Lomb Americas | Meals · 2025-01-06 | Miebo | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $465
| Alcon Vision | Centurion | $196 | 3 payments
|
| Abbvie | Durysta | $61 | 2 payments
|
| Regeneron Healthcare Solutions | Eylea Hd | $39 | 1 payment
|
| Genentech USA | Vabysmo | $32 | 1 payment
|
| Genentech | Vabysmo | $31 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $30 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $28 | 1 payment
|
| RxSight | Rxsight Contact Lens | $24 | 1 payment
|
| Surgical Specialties Corporation (us) Inc. (dba Corza Medical) | None | $24 | 1 payment
|
2023: $367
| AbbVie | Durysta | $149 | 6 payments
|
| Oyster Point Pharma | Tyrvaya | $87 | 3 payments
|
| Bausch & Lomb Americas | Envista Mx60 Iol | $47 | 1 payment
|
| Carl Zeiss Meditec USA | Visuref 100 | $38 | 1 payment
|
| Apellis Pharmaceuticals | Syfovre | $24 | 1 payment
|
| Biotissue Holdings | Prokera | $23 | 1 payment
|
2022: $258
| BioTissue Holdings | Prokera | $118 | 4 payments
|
| Alcon Vision | Simbrinza | $46 | 2 payments
|
| Genentech USA | Vabysmo | $27 | 1 payment
|
| Allergan | Vuity | $25 | 1 payment
|
| Bausch & Lomb Americas | Prolensa | $23 | 1 payment
|
| Dompe US | Oxervate | $20 | 1 payment
|
2021: $285
| Carl Zeiss Meditec USA | Forum | $93 | 1 payment
|
| Aerie Pharmaceuticals | Rocklatan | $67 | 3 payments
|
| Tissuetech | Prokera | $45 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Stellaris | $25 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $23 | 1 payment
|
| Allergan | Restasis Multidose | $18 | 1 payment
|
| Dompe US | Oxervate | $14 | 1 payment
|
2020: $10,742
| Carl Zeiss Meditec | Clarus | $10,637 | 3 payments
|
| TissueTech | Prokera | $58 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $47 | 2 payments
|
2019: $1,256
| Johnson & Johnson Surgical Vision | Tecnis 1-Piece Iol | $1,035 | 8 payments
|
| Novartis Pharmaceuticals | Travatan Z | $127 | 1 payment
|
| TissueTech | Prokera | $70 | 2 payments
|
| Allergan | Lumigan | $24 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Carl Zeiss Meditec, Inc. · Clarus Diabetic Retinopathy Study · 2021 | This clinician | $14,886 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1447322169
- Licence
- CA G69615California G69615: Current · expires 2028-06-30
- Trained
- University of California, San Francisco School of Medicine, 1989 · 37 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207WX0107X (207WX0107X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 3201 Mission St, San Francisco, CA, 94110
- NPI first listed
- 2006-11-15
- NPI last updated
- 2025-10-24
- NPI record certified
- 2025-10-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1100 Van Ness Ave Fl 5, San Francisco, CA, 94109